TiGenix up 4% on €10M Takeda investment

|About: Takeda Pharmaceutical ... (TAK)|By:, SA News Editor

Takeda Pharmaceutical (OTCPK:TKPHF)(OTCPK:TKPYY) exercises its option to invest €10M in Belgian biotech TiGenix NV (TIG +4%) by purchasing 11,651,778 newly issued ordinary shares at €0.858. The new shares, subject to a one-year lockup, should be issued in the first week of January.

Previously: Takeda nabs ex-U.S. rights to investigational stem cell treatment for Crohn's-related fistulas (July 5)

Subscribe for full text news in your inbox